Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Nov 16, 2021

Later deadlines: Jan 7, 2022

Grant amount: Up to US $275,000

Fields of work: Infectious & Parasitic Diseases

Applicant type: Organizations

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

This Funding Opportunity Announcement (FOA) invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to protective immune responses against:

  • Infectious disease pathogens and/or vaccines;
  • Pathogen-associated immune pathogenesis; and/or
  • Limit progression or induction of immune-mediated diseases.

These studies may facilitate the development of novel tools and reagents to advance design of immune-based therapeutics and vaccines.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed November 15, 2018 and last updated November 15, 2018